We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-3.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.7B
AUM Growth
-$119M
Cap. Flow
-$1.99M
Cap. Flow %
-0.12%
Top 10 Hldgs %
26.27%
Holding
258
New
9
Increased
68
Reduced
165
Closed
10

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$11.6M
2
LKQ icon
LKQ Corp
LKQ
+$10.4M
3
DOX icon
Amdocs
DOX
+$9.78M
4
GTLS
Chart Industries
GTLS
+$8.47M
5
FOLD
Amicus Therapeutics
FOLD
+$5.91M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$25.9M
2
TKO icon
TKO Group
TKO
+$9.39M
3
VRNA
Verona Pharma
VRNA
+$7.87M
4
HLIT icon
Harmonic Inc
HLIT
+$3.61M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$3.11M

Sector Composition

Rank Sector Weight
1 Healthcare 32.28%
2 Technology 27.73%
3 Industrials 15.51%
4 Consumer Discretionary 7.22%
5 Communication Services 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRN icon
26
Ituran Location and Control
ITRN
$1.05B
$17.7M 1.04%
489,917
-17,635
-3% -$636K
LMAT icon
27
LeMaitre Vascular
LMAT
$1.86B
$17.7M 1.04%
210,622
-24,454
-10% -$2.27M
TRAK icon
28
ReposiTrak
TRAK
$159M
$17.3M 1.02%
853,017
-74,295
-8% -$1.54M
SUPN icon
29
Supernus Pharmaceuticals
SUPN
$2.77B
$16.9M 0.99%
515,889
-12,456
-2% -$441K
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
$16.4M 0.96%
2,010,104
+639,024
+47% +$5.91M
RBA icon
31
RB Global
RBA
$17.5B
$16.4M 0.96%
163,390
-2,262
-1% -$216K
BCRX icon
32
BioCryst Pharmaceuticals
BCRX
$2.4B
$15.2M 0.89%
2,027,568
-53,748
-3% -$434K
WIX icon
33
WIX.com
WIX
$2.52B
$14.6M 0.86%
89,078
-700
-0.8% -$145K
FC icon
34
Franklin Covey
FC
$246M
$14.5M 0.85%
523,795
-10,129
-2% -$335K
NGVT icon
35
Ingevity
NGVT
$2.68B
$14.4M 0.85%
364,216
+7,947
+2% +$352K
CRAI icon
36
CRA International
CRAI
$1.06B
$14.1M 0.83%
81,491
-3,156
-4% -$584K
ALKS icon
37
Alkermes
ALKS
$8.25B
$14.1M 0.83%
426,585
-3,342
-0.8% -$109K
KNSA icon
38
Kiniksa Pharmaceuticals
KNSA
$5.93B
$13.9M 0.82%
624,545
-18,207
-3% -$375K
MMS icon
39
Maximus
MMS
$3.1B
$12.7M 0.74%
185,780
+13,234
+8% +$943K
SSTK icon
40
Shutterstock
SSTK
$219M
$12.4M 0.73%
666,348
+118,828
+22% +$3.04M
OZK icon
41
Bank OZK
OZK
$5.61B
$12.3M 0.72%
283,520
-3,496
-1% -$165K
NBIX icon
42
Neurocrine Biosciences
NBIX
$16.6B
$12.1M 0.71%
109,673
-959
-0.9% -$121K
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$5.03B
$11.2M 0.66%
672,223
-9,314
-1% -$169K
CEVA icon
44
CEVA Inc
CEVA
$1.08B
$11.2M 0.66%
435,478
-11,883
-3% -$382K
EOLS icon
45
Evolus
EOLS
$501M
$11.1M 0.65%
921,394
-26,887
-3% -$352K
POOL icon
46
Pool Corp
POOL
$7.5B
$10.7M 0.63%
33,711
-256
-0.8% -$86.8K
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$6.14B
$10.6M 0.62%
234,696
-4,303
-2% -$203K
GNTX icon
48
Gentex
GNTX
$5.07B
$10.5M 0.62%
451,010
-3,873
-0.9% -$99K
LQDT icon
49
Liquidity Services
LQDT
$1.32B
$9.48M 0.56%
305,782
-28,473
-9% -$947K
MTN icon
50
Vail Resorts
MTN
$5.3B
$9.46M 0.56%
59,139
-76
-0.1% -$12.6K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Rice Hall James & Associates held 258 positions worth $1.7B, down 6.5% from $1.82B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q1 2025 filing shows 9 new, 68 increased, 165 reduced and 10 closed positions. Its largest new stake was Chart Industries: 45,975 shares worth $6.64M. The largest sale was Stride, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q1 2025 buy was Chart Industries: 45,975 shares worth $6.64M.
  • Rice Hall James & Associates added most to Shift4 in Q1 2025, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2025 reduction was Stride, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Harmonic Inc in Q1 2025, selling an estimated $3.61M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.7B portfolio in Q1 2025.
  • Rice Hall James & Associates opened 9 new positions and closed 10 in Q1 2025.
  • Rice Hall James & Associates's portfolio value fell 6.5% quarter-over-quarter to $1.7B.

Based on Rice Hall James & Associates's 13F filing for Q1 2025, filed 1 May 2025.